Find Out Why Connecticut’s Protein Sciences Corp Is Making Its Waves On Zika Vaccine, Can They Finally Hold The Answer To The Problem?
With the Zika virus cases continuously rising, the perfect cure is yet to be officially recognized by health experts from across the globe. Until Protein Sciences Corp. has recently revealed that the company is currently on the move to be developing a Zika vaccine that has already been doing well in pre-clinical trials and could begin being tested on humans by April. It was found that the drug that is being developed by the Connecticut-based biotech company is known to be reportedly composed of a purified type of protein, which, in turn, has the ability to match one found on the outer surface of the Zika virus. Experts have revealed that pre-clinical testing stage is a necessary part of the process in order to make sure that a drug candidate does not have the potential to cause serious harm.
Connecticut's Protein Sciences Corp Is Making Its Waves On Zika Vaccine
According to reports revealed by Bethwood Patch, authorities of the project said that they are in fact in partnership with Buenos Aries-based Sinergium Biotech and the Mundo Sano Foundation on the vaccine, will allegedly utilize Protein Sciences' proprietary technology. In return, the agreement includes Sinergium to be paying for an undisclosed upfront fee, in order to fund the development and manufacture of the vaccine, and Mundo, on the other hand, will expectedly assist in various ways, which includes reaching those affected by the disease.
Furthermore, in one of their statements reported by New Haven Register News, the company's executives said that a separate study focusing on a Zika virus candidate, which has been sponsored by National Institute of Allergy and Infectious Disease, National Institutes of Health, has apparently yielded good safety data. Ultimately, Max Cox, president and chief executive officer of Protein Sciences has added that Zika disappointingly remains as a crucial threat in several parts of the world, which makes them even more convinced that the project they're currently working on would be able to bring them into a step closer to realizing that there is indeed a certain kind of vaccine that will be able to protect humans against this deadly virus.
Everything You Have To Know About Why Zika Virus Will Not Likely Take Place In The US As Revealed By Health Experts, Details Inside
With the Zika virus starting to become a global pandemic disease, how did a number of health experts come up with their conclusion that Zika outbreak is not likely to take place in the US? Does it mean that the country will ever be safe from the said disease? Here’s what health authorities have to reveal
Zika Virus Imminent Threat To Babies
It is a public health epidemic concern for the world. 69 countries have seen the Zika virus emerges for the last two years. We are talking about a virus that causes long-term brain damage and disability, which is a huge emotional burden to families.
MORE IN ITECHPOST
Alcatel Launches A 'Party-Themed' Midrange Smartphone
Spotted at the 2017 MWC is the Alcatel A5 LED (aka Disco Phone) that features three changeable back accessories with pulsing lights and pumping bass.
Apitope's Peptide Vaccine Finally Sheds Light To Multiple Sclerosis; Details Inside
With the continuous efforts to eradicate Multiple Sclerosis, how significant is Apitope's peptide vaccine for the said auto-immune disease? Could this vaccine be the advent of new medications to treat one of the diseases that has already affected millions of lives? Find out what experts have to say
Lazy Bear Games' 'Graveyard Keeper' Released First Trailer
Check out the amazing graveyard simulator entitled Graveyard Keeper.